Incretin hormones, obesity and gut microbiota
That convenience factor may tip scales in favor of Lilly's pill, if and when it's approved, said Evan Seigerman, a financial analyst who follows both companies closely for Wall Street firm BMO Capital Markets
Contact your healthcare provider if headaches are severe, persistent, or accompanied by neurological symptoms for appropriate evaluation and management
Who injections are better for: People who want evidence-based, FDA-approved therapy Those eligible for insurance reimbursement Patients with diabetes or cardiovascular risks Anyone prioritizing consistent, measurable results Who patches may appeal to: People afraid of needles Curious biohackers who want to try supplements rather than true GLP-1s Those willing to experiment with their health Expert Opinion C
Exercise timing also matters
Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR)